510(k) Report

De Novo · Granted

Granted

Lyra Direct Strep Assay

DEN140005De NovoGranted Apr 16, 201422-day reviewClass II21 CFR 866.2680

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Quidel Corporation · PGX Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System

Granted on Apr 16, 2014 as a new device type through De Novo after a 22-day review. 1 of the 24 devices in its family, counting itself, has a Class I recall. 23 later devices descend from it.

Decided
Apr 16, 2014
Review
22 days
Class
Class II
Product code
PGX
Recalls
None

23 later devices descend from it, 6 citing it directly. 1 of the 24 devices in this family, counting this one, has a Class I recall.

Descendants, by year cleared 2016: 1 descendant cleared2014: 2 descendants cleared2015: 4 descendants cleared, 1 with a Class I recall12017: 2 descendants cleared2020: 2 descendants cleared2018: 3 descendants cleared2026: 3 descendants cleared2022: 2 descendants cleared2021: 1 descendant cleared2019: 2 descendants cleared2023: 1 descendant cleared2010201520202025
  1. This deviceDEN140005 Lyra Direct Strep AssayQuidel Corporation · 2014
  2. Descendant · cites it directly · 8 of its ownK141757 Alere I Strep aAlere Scarborough, Inc. · 2015
  3. Descendant · cites it directly · 8 of its ownK141338 Liat Strep a AssayIquum, Inc. · 2014
  4. Descendant · 2 generations on · 4 of its ownK151690 Alere i Instrument, Alere i Influenza A & B, Alere i Strep AAlere Scarborough, Inc. · 2015
  5. Descendant · 2 generations on · 3 of its ownK200065 cobas Influenza A/B Nucleic acid test for use on the cobas Liat…Roche Molecular Systems, Inc. · 2020
  6. Descendant · 2 generations on · 3 of its ownK173653 Alere i Strep A 2, Alere i instrument, Alere i Strep A 2 Control…Alere Scarborough, Inc. · 2018

Showing 5 of 23 descendants. See all descendants

Descendants cleared per year

2014: 22015: 42016: 12017: 22018: 32019: 22020: 22021: 12022: 22023: 12026: 3
2014high 4 (2015) · low 0 (2024)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 23 · See all
  • K141757Alere I Strep aAlere Scarborough, Inc. · 2015 · cites it directly8descendants
  • K141338Liat Strep a AssayIquum, Inc. · 2014 · cites it directly8descendants
  • K151690Alere i Instrument, Alere i Influenza A & B, Alere i Strep AAlere Scarborough, Inc. · 2015 · 2 generations on4descendants
  • K200065cobas Influenza A/B Nucleic acid test for use on the cobas Liat System, cobas Influenza…Roche Molecular Systems, Inc. · 2020 · 2 generations on3descendants
  • K173653Alere i Strep A 2, Alere i instrument, Alere i Strep A 2 Control Swab KitAlere Scarborough, Inc. · 2018 · 2 generations on3descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)DEN140005Lyra Direct Strep AssayQuidel Corporation2014—
+1K141757Alere I Strep aAlere Scarborough, Inc.2015—
+1K141338Liat Strep a AssayIquum, Inc.2014—
+2K151690Alere i Instrument, Alere i Influenza A & B, Alere i Strep AAlere Scarborough, Inc.2015—
+2K200065cobas Influenza A/B Nucleic acid test for use on the cobas Liat System, cobas…Roche Molecular Systems, Inc.2020—
+2K173653Alere i Strep A 2, Alere i instrument, Alere i Strep A 2 Control Swab KitAlere Scarborough, Inc.2018—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201420
201541
201610
201720
201830
201920
202020
202110
202220
202310
202630
FIG. 1 — Lineage of DEN140005, 2014–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA De Novo database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PGX device

  1. #1 K260047 cobas Strep A Nucleic acid test for use on the…score 14.0 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

Does it have a predicate?

De Novo decisions do not claim a predicate device.

What descends from it? (23)

See all 23

6 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K141757Alere I Strep aAlere Scarborough, Inc.20158
K141338Liat Strep a AssayIquum, Inc.20148
K143651Simplexa Group A Strep Direct, Simplexa Group A Strep Positive Control Pack Class IFocus Diagnostics, Inc.20151
K162274Solana Strep Complete AssayQuidel Corporation20160
K150868Solana GAS Assay, Solana instrumentQuidel Corporation20150
K141173Amplivue Gas AssayQuidel Corporation20140

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K143651Simplexa Group A Strep Direct, Simplexa Group A Strep Positive Control PackFocus Diagnostics, Inc. · 2015 · Cites it directly · ◆ in the 2015 descendants bar of FIG. 11 Class I recall

What does this lineage say?

  • Of its descendants, K141757 (Alere Scarborough, Inc., 2015) has gone furthest, with 8 descendants of its own.

How does its category compare?

All PGX devices

PGX Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · PGX

1in 2020

2014: 32015: 32016: 12017: 22018: 22019: 12020: 12026 (partial year): 2
2007high 3 (2014) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PGX

85in 2015

2015: 85 days median
2007high 85 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PGX

2in 2023

2023: 2
2007high 2 (2023) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PGX

1in 2022

2019: 22022: 1
2007high 2 (2019) · low 0 (2007)2025

MAUDE reports naming product code PGX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20143—00
201538500
20161—00
20172—00
20182—00
20191—02
20201—00
20210—00
20220—01
20230—20
20240—00
20250—00
20262—0—
Cite this page

510(k) Report. “DEN140005: Lyra Direct Strep Assay.” Lineage record from FDA De Novo data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/DEN140005

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026